1. Home
  2. MRBK vs ENTA Comparison

MRBK vs ENTA Comparison

Compare MRBK & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRBK
  • ENTA
  • Stock Information
  • Founded
  • MRBK 2004
  • ENTA 1995
  • Country
  • MRBK United States
  • ENTA United States
  • Employees
  • MRBK N/A
  • ENTA N/A
  • Industry
  • MRBK Major Banks
  • ENTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MRBK Finance
  • ENTA Health Care
  • Exchange
  • MRBK Nasdaq
  • ENTA Nasdaq
  • Market Cap
  • MRBK 185.1M
  • ENTA 154.0M
  • IPO Year
  • MRBK 2017
  • ENTA 2013
  • Fundamental
  • Price
  • MRBK $14.30
  • ENTA $5.30
  • Analyst Decision
  • MRBK Buy
  • ENTA Buy
  • Analyst Count
  • MRBK 2
  • ENTA 4
  • Target Price
  • MRBK $16.00
  • ENTA $17.25
  • AVG Volume (30 Days)
  • MRBK 58.5K
  • ENTA 221.2K
  • Earning Date
  • MRBK 04-25-2025
  • ENTA 05-05-2025
  • Dividend Yield
  • MRBK 3.50%
  • ENTA N/A
  • EPS Growth
  • MRBK 25.00
  • ENTA N/A
  • EPS
  • MRBK 1.45
  • ENTA N/A
  • Revenue
  • MRBK $100,935,000.00
  • ENTA $66,590,999.00
  • Revenue This Year
  • MRBK $22.20
  • ENTA N/A
  • Revenue Next Year
  • MRBK $9.93
  • ENTA N/A
  • P/E Ratio
  • MRBK $9.86
  • ENTA N/A
  • Revenue Growth
  • MRBK 7.27
  • ENTA N/A
  • 52 Week Low
  • MRBK $8.26
  • ENTA $4.71
  • 52 Week High
  • MRBK $17.33
  • ENTA $17.60
  • Technical
  • Relative Strength Index (RSI)
  • MRBK 42.17
  • ENTA 30.12
  • Support Level
  • MRBK $14.15
  • ENTA $5.65
  • Resistance Level
  • MRBK $14.93
  • ENTA $5.96
  • Average True Range (ATR)
  • MRBK 0.38
  • ENTA 0.34
  • MACD
  • MRBK 0.09
  • ENTA -0.14
  • Stochastic Oscillator
  • MRBK 46.15
  • ENTA 4.89

About MRBK Meridian Corporation

Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

Share on Social Networks: